 | • レポートコード：QYR2104Z0960 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ボツリヌス中毒のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、抗毒素、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ボツリヌス中毒の市場動向 ・企業の競争状況、市場シェア ・ボツリヌス中毒の種類別市場規模（抗生物質、抗毒素、その他） ・ボツリヌス中毒の用途別市場規模（病院、クリニック、その他） ・ボツリヌス中毒の北米市場規模2016-2027（アメリカ、カナダ） ・ボツリヌス中毒のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ボツリヌス中毒のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ボツリヌス中毒の中南米市場規模2016-2027（メキシコ、ブラジル） ・ボツリヌス中毒の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Microbiotix、XOMA Corporation、Molecular Targeting Technologies、AlphaVax、Morphotek） ・結論 |
Botulism is a rare and potentially fatal illness caused by a toxin produced by the bacterium Clostridium botulinum. The diseasebegins with weakness, blurred vision, feeling tired, and trouble speaking.
Market Analysis and Insights: Global Botulism Illness Market
The global Botulism Illness market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Botulism Illness market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Botulism Illness market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Botulism Illness market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Botulism Illness market.
Global Botulism Illness Scope and Market Size
Botulism Illness market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Botulism Illness market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Antibiotics
Antitoxins
Other
Segment by Application
Hospitals
Clinics
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Microbiotix
XOMA Corporation
Molecular Targeting Technologies
AlphaVax
Morphotek
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Botulism Illness Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibiotics
1.2.3 Antitoxins
1.2.4 Other
1.3 Market by Application
1.3.1 Global Botulism Illness Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Botulism Illness Market Perspective (2016-2027)
2.2 Botulism Illness Growth Trends by Regions
2.2.1 Botulism Illness Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Botulism Illness Historic Market Share by Regions (2016-2021)
2.2.3 Botulism Illness Forecasted Market Size by Regions (2022-2027)
2.3 Botulism Illness Industry Dynamic
2.3.1 Botulism Illness Market Trends
2.3.2 Botulism Illness Market Drivers
2.3.3 Botulism Illness Market Challenges
2.3.4 Botulism Illness Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Botulism Illness Players by Revenue
3.1.1 Global Top Botulism Illness Players by Revenue (2016-2021)
3.1.2 Global Botulism Illness Revenue Market Share by Players (2016-2021)
3.2 Global Botulism Illness Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Botulism Illness Revenue
3.4 Global Botulism Illness Market Concentration Ratio
3.4.1 Global Botulism Illness Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Botulism Illness Revenue in 2020
3.5 Botulism Illness Key Players Head office and Area Served
3.6 Key Players Botulism Illness Product Solution and Service
3.7 Date of Enter into Botulism Illness Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Botulism Illness Breakdown Data by Type
4.1 Global Botulism Illness Historic Market Size by Type (2016-2021)
4.2 Global Botulism Illness Forecasted Market Size by Type (2022-2027)
5 Botulism Illness Breakdown Data by Application
5.1 Global Botulism Illness Historic Market Size by Application (2016-2021)
5.2 Global Botulism Illness Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Botulism Illness Market Size (2016-2027)
6.2 North America Botulism Illness Market Size by Type
6.2.1 North America Botulism Illness Market Size by Type (2016-2021)
6.2.2 North America Botulism Illness Market Size by Type (2022-2027)
6.2.3 North America Botulism Illness Market Size by Type (2016-2027)
6.3 North America Botulism Illness Market Size by Application
6.3.1 North America Botulism Illness Market Size by Application (2016-2021)
6.3.2 North America Botulism Illness Market Size by Application (2022-2027)
6.3.3 North America Botulism Illness Market Size by Application (2016-2027)
6.4 North America Botulism Illness Market Size by Country
6.4.1 North America Botulism Illness Market Size by Country (2016-2021)
6.4.2 North America Botulism Illness Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Botulism Illness Market Size (2016-2027)
7.2 Europe Botulism Illness Market Size by Type
7.2.1 Europe Botulism Illness Market Size by Type (2016-2021)
7.2.2 Europe Botulism Illness Market Size by Type (2022-2027)
7.2.3 Europe Botulism Illness Market Size by Type (2016-2027)
7.3 Europe Botulism Illness Market Size by Application
7.3.1 Europe Botulism Illness Market Size by Application (2016-2021)
7.3.2 Europe Botulism Illness Market Size by Application (2022-2027)
7.3.3 Europe Botulism Illness Market Size by Application (2016-2027)
7.4 Europe Botulism Illness Market Size by Country
7.4.1 Europe Botulism Illness Market Size by Country (2016-2021)
7.4.2 Europe Botulism Illness Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Botulism Illness Market Size (2016-2027)
8.2 Asia-Pacific Botulism Illness Market Size by Type
8.2.1 Asia-Pacific Botulism Illness Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Botulism Illness Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Botulism Illness Market Size by Type (2016-2027)
8.3 Asia-Pacific Botulism Illness Market Size by Application
8.3.1 Asia-Pacific Botulism Illness Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Botulism Illness Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Botulism Illness Market Size by Application (2016-2027)
8.4 Asia-Pacific Botulism Illness Market Size by Region
8.4.1 Asia-Pacific Botulism Illness Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Botulism Illness Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Botulism Illness Market Size (2016-2027)
9.2 Latin America Botulism Illness Market Size by Type
9.2.1 Latin America Botulism Illness Market Size by Type (2016-2021)
9.2.2 Latin America Botulism Illness Market Size by Type (2022-2027)
9.2.3 Latin America Botulism Illness Market Size by Type (2016-2027)
9.3 Latin America Botulism Illness Market Size by Application
9.3.1 Latin America Botulism Illness Market Size by Application (2016-2021)
9.3.2 Latin America Botulism Illness Market Size by Application (2022-2027)
9.3.3 Latin America Botulism Illness Market Size by Application (2016-2027)
9.4 Latin America Botulism Illness Market Size by Country
9.4.1 Latin America Botulism Illness Market Size by Country (2016-2021)
9.4.2 Latin America Botulism Illness Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Botulism Illness Market Size (2016-2027)
10.2 Middle East & Africa Botulism Illness Market Size by Type
10.2.1 Middle East & Africa Botulism Illness Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Botulism Illness Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Botulism Illness Market Size by Type (2016-2027)
10.3 Middle East & Africa Botulism Illness Market Size by Application
10.3.1 Middle East & Africa Botulism Illness Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Botulism Illness Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Botulism Illness Market Size by Application (2016-2027)
10.4 Middle East & Africa Botulism Illness Market Size by Country
10.4.1 Middle East & Africa Botulism Illness Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Botulism Illness Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Microbiotix
11.1.1 Microbiotix Company Details
11.1.2 Microbiotix Business Overview
11.1.3 Microbiotix Botulism Illness Introduction
11.1.4 Microbiotix Revenue in Botulism Illness Business (2016-2021)
11.1.5 Microbiotix Recent Development
11.2 XOMA Corporation
11.2.1 XOMA Corporation Company Details
11.2.2 XOMA Corporation Business Overview
11.2.3 XOMA Corporation Botulism Illness Introduction
11.2.4 XOMA Corporation Revenue in Botulism Illness Business (2016-2021)
11.2.5 XOMA Corporation Recent Development
11.3 Molecular Targeting Technologies
11.3.1 Molecular Targeting Technologies Company Details
11.3.2 Molecular Targeting Technologies Business Overview
11.3.3 Molecular Targeting Technologies Botulism Illness Introduction
11.3.4 Molecular Targeting Technologies Revenue in Botulism Illness Business (2016-2021)
11.3.5 Molecular Targeting Technologies Recent Development
11.4 AlphaVax
11.4.1 AlphaVax Company Details
11.4.2 AlphaVax Business Overview
11.4.3 AlphaVax Botulism Illness Introduction
11.4.4 AlphaVax Revenue in Botulism Illness Business (2016-2021)
11.4.5 AlphaVax Recent Development
11.5 Morphotek
11.5.1 Morphotek Company Details
11.5.2 Morphotek Business Overview
11.5.3 Morphotek Botulism Illness Introduction
11.5.4 Morphotek Revenue in Botulism Illness Business (2016-2021)
11.5.5 Morphotek Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Botulism Illness Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibiotics
Table 3. Key Players of Antitoxins
Table 4. Key Players of Other
Table 5. Global Botulism Illness Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Botulism Illness Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Botulism Illness Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Botulism Illness Market Share by Regions (2016-2021)
Table 9. Global Botulism Illness Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Botulism Illness Market Share by Regions (2022-2027)
Table 11. Botulism Illness Market Trends
Table 12. Botulism Illness Market Drivers
Table 13. Botulism Illness Market Challenges
Table 14. Botulism Illness Market Restraints
Table 15. Global Botulism Illness Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Botulism Illness Market Share by Players (2016-2021)
Table 17. Global Top Botulism Illness Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Botulism Illness as of 2020)
Table 18. Ranking of Global Top Botulism Illness Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Botulism Illness Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Botulism Illness Product Solution and Service
Table 22. Date of Enter into Botulism Illness Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Botulism Illness Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Botulism Illness Revenue Market Share by Type (2016-2021)
Table 26. Global Botulism Illness Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Botulism Illness Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Botulism Illness Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Botulism Illness Revenue Market Share by Application (2016-2021)
Table 30. Global Botulism Illness Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Botulism Illness Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Botulism Illness Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Botulism Illness Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Botulism Illness Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Botulism Illness Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Botulism Illness Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Botulism Illness Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Botulism Illness Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Botulism Illness Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Botulism Illness Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Botulism Illness Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Botulism Illness Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Botulism Illness Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Botulism Illness Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Botulism Illness Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Botulism Illness Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Botulism Illness Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Botulism Illness Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Botulism Illness Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Botulism Illness Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Botulism Illness Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Botulism Illness Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Botulism Illness Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Botulism Illness Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Botulism Illness Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Botulism Illness Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Botulism Illness Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Botulism Illness Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Botulism Illness Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Botulism Illness Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Botulism Illness Market Size by Country (2022-2027) & (US$ Million)
Table 62. Microbiotix Company Details
Table 63. Microbiotix Business Overview
Table 64. Microbiotix Botulism Illness Product
Table 65. Microbiotix Revenue in Botulism Illness Business (2016-2021) & (US$ Million)
Table 66. Microbiotix Recent Development
Table 67. XOMA Corporation Company Details
Table 68. XOMA Corporation Business Overview
Table 69. XOMA Corporation Botulism Illness Product
Table 70. XOMA Corporation Revenue in Botulism Illness Business (2016-2021) & (US$ Million)
Table 71. XOMA Corporation Recent Development
Table 72. Molecular Targeting Technologies Company Details
Table 73. Molecular Targeting Technologies Business Overview
Table 74. Molecular Targeting Technologies Botulism Illness Product
Table 75. Molecular Targeting Technologies Revenue in Botulism Illness Business (2016-2021) & (US$ Million)
Table 76. Molecular Targeting Technologies Recent Development
Table 77. AlphaVax Company Details
Table 78. AlphaVax Business Overview
Table 79. AlphaVax Botulism Illness Product
Table 80. AlphaVax Revenue in Botulism Illness Business (2016-2021) & (US$ Million)
Table 81. AlphaVax Recent Development
Table 82. Morphotek Company Details
Table 83. Morphotek Business Overview
Table 84. Morphotek Botulism Illness Product
Table 85. Morphotek Revenue in Botulism Illness Business (2016-2021) & (US$ Million)
Table 86. Morphotek Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Botulism Illness Market Share by Type: 2020 VS 2027
Figure 2. Antibiotics Features
Figure 3. Antitoxins Features
Figure 4. Other Features
Figure 5. Global Botulism Illness Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Botulism Illness Report Years Considered
Figure 10. Global Botulism Illness Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Botulism Illness Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Botulism Illness Market Share by Regions: 2020 VS 2027
Figure 13. Global Botulism Illness Market Share by Regions (2022-2027)
Figure 14. Global Botulism Illness Market Share by Players in 2020
Figure 15. Global Top Botulism Illness Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Botulism Illness as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Botulism Illness Revenue in 2020
Figure 17. Global Botulism Illness Revenue Market Share by Type (2016-2021)
Figure 18. Global Botulism Illness Revenue Market Share by Type (2022-2027)
Figure 19. North America Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Botulism Illness Market Share by Type (2016-2027)
Figure 21. North America Botulism Illness Market Share by Application (2016-2027)
Figure 22. North America Botulism Illness Market Share by Country (2016-2027)
Figure 23. United States Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Botulism Illness Market Share by Type (2016-2027)
Figure 27. Europe Botulism Illness Market Share by Application (2016-2027)
Figure 28. Europe Botulism Illness Market Share by Country (2016-2027)
Figure 29. Germany Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Botulism Illness Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Botulism Illness Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Botulism Illness Market Share by Region (2016-2027)
Figure 39. China Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Botulism Illness Market Share by Type (2016-2027)
Figure 47. Latin America Botulism Illness Market Share by Application (2016-2027)
Figure 48. Latin America Botulism Illness Market Share by Country (2016-2027)
Figure 49. Mexico Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Botulism Illness Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Botulism Illness Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Botulism Illness Market Share by Country (2016-2027)
Figure 55. Turkey Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Botulism Illness Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Microbiotix Revenue Growth Rate in Botulism Illness Business (2016-2021)
Figure 59. XOMA Corporation Revenue Growth Rate in Botulism Illness Business (2016-2021)
Figure 60. Molecular Targeting Technologies Revenue Growth Rate in Botulism Illness Business (2016-2021)
Figure 61. AlphaVax Revenue Growth Rate in Botulism Illness Business (2016-2021)
Figure 62. Morphotek Revenue Growth Rate in Botulism Illness Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
世界のボツリヌス中毒治療市場規模・現状・予測（2021年-2027年） Botulism is a type of poisoning or infection caused by certain bacteria on the preserved food material. The overall botulism market also provides a detailed analysis of the type and treatment in various regions which includes Americas, Europe, Asia Pacific and Rest of the World. Americas lead the bo…- 世界のインストアヘルスクリニック市場規模・現状・予測（2021年-2027年） In store Health Clinics are a category of walk in clinics, which are located in supermarkets, retail stores, and pharmacies. Market Analysis and Insights: Global In-store Health Clinics Market The global In-store Health Clinics market size is projected to reach US$ XX million by 2026, from US$ XX mi…
- 世界のリパーパシングドラッグ市場規模・現状・予測（2021年-2027年） Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a …
- 世界のアミノグリコシド系抗生物質薬剤市場規模・現状・予測（2021年-2027年） Aminoglycosides are potent bactericidal antibiotics that act by creating fissures in the outer membrane of the bacterial cell. They are particularly active against aerobic, gram-negative bacteria and act synergistically against certain gram-positive organisms. Market Analysis and Insights: Global Am…
- 世界の緊急医療センター市場規模・現状・予測（2021年-2027年） Urgent care is a category of walk-in clinic focused on the delivery of ambulatory care in a dedicated medical facility outside of a traditional emergency department (emergency room). Urgent care centers primarily treat injuries or illnesses requiring immediate care, but not serious enough to require…